RxDoctor Payments Data

Adam Allie, MD

Family Medicine · Murfreesboro, TNNPI 1962664680

Payments from drug & device makers

$2,927in general payments, 2019–2025

Across 166 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$434
  • Astellas Pharma US Inc$400
  • Novo Nordisk$360
  • AbbVie$336
  • Otsuka America Pharmaceutical, Inc.$331
  • Amgen$226
  • plus $840 from 18 others

What the payments were for

  • Food & beverage$2,86698%
  • Education$612%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,927 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$94,107
Medicare patients
243
Services billed
3,243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$39,264
MounjaroTirzepatide35$36,983
RybelsusSemaglutide17$23,691
EliquisApixaban13$17,724
Breo ElliptaFluticasone/Vilanterol32$15,941
JardianceEmpagliflozin16$15,256
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$10,637
XareltoRivaroxaban12$10,395
TrulicityDulaglutide11$10,334
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$9,708
Atorvastatin Calcium408$5,182
SynthroidLevothyroxine Sodium65$5,118
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,524
Bupropion XlBupropion Hcl14$2,679
Testosterone Cypionate31$2,416

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$360$62,95651 claims
Lilly USA, LLCMounjaro, Trulicity$87$47,31746 claims
GSKBreo Ellipta, Shingrix$94$19,46548 claims
PfizerEliquis$434$17,72413 claims
Boehringer IngelheimJardiance$33$15,25616 claims
Johnson & JohnsonXarelto$26$10,39512 claims
AbbVieSynthroid$336$5,11865 claims
Sanofi-aventis U.S. LLCLantus$13$1,34512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →